Abstract
In this review, we discuss the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is characterised by extreme mental and physical fatigue with associated symptoms of pain, disturbed sleep, cognitive and autonomic dysfunction, as well as post-exertional malaise. This con-dition is often preceded by an infection, severe physiological and/or psychological strain. Over the last decades, research has demonstrated mitochondrial, neuroendocrine, immuno-logical, and metabolic perturbations in patients with ME/CFS, giving hope for the development of new biomarkers and new treatment modalities.
Bidragets oversatte titel | Myalgic encephalomyelitis or chronic fatigue syndrome |
---|---|
Originalsprog | Dansk |
Artikelnummer | V08180570 |
Sider (fra-til) | 2025-2027 |
Antal sider | 3 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 181 |
Udgave nummer | 24 |
Status | Udgivet - 10 jun. 2019 |
Emneord
- Biomarkers
- Fatigue Syndrome, Chronic/diagnosis
- Humans
- Mitochondria
- Pain